Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019).

Thanks to the past, present, and future research, in the next few years we will see progress in the treatment of some diseases with GSK3i, for instance in regenerative medicine immunotherapy applications among others.